Argent Trust CO Novartis Ag Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Argent Trust CO holds 35,015 shares of NVS stock, worth $3.44 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

35,015

Previous 35,575 1.57%

Holding current value

$3.44 Million

Previous $3.79 Million 6.34%

% of portfolio

0.17%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $59,432 - $67,698	-560 Reduced 1.57%	35,015 $4.03 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $145,705 - $169,000	1,574 Added 4.63%	35,575 $3.79 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $39,727 - $45,231	-417 Reduced 1.21%	34,001 $3.29 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $32,386 - $35,640	-351 Reduced 1.01%	34,418 $3.48 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $14,398 - $15,979	-152 Reduced 0.44%	34,769 $3.54 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $77,716 - $88,124	-840 Reduced 2.35%	34,921 $3.52 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $105,879 - $122,787	1,323 Added 3.84%	35,761 $3.29 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $216,299 - $264,884	-2,863 Reduced 7.68%	34,438 $3.12 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $63,940 - $74,781	857 Added 2.35%	37,301 $2.84 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $12,561 - $14,625	-156 Reduced 0.43%	36,444 $3.08 Million
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $20,267 - $22,926	-253 Reduced 0.69%	36,600 $3.21 Million
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $105,204 - $116,331	-1,320 Reduced 3.46%	36,853 $3.22 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $13,820 - $16,078	169 Added 0.44%	38,173 $3.12 Million
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $28,896 - $31,916	339 Added 0.9%	38,004 $3.47 Million
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $75,651 - $89,213	906 Added 2.46%	37,665 $3.22 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $245,061 - $296,415	-3,139 Reduced 7.87%	36,759 $3.47 Million
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $136,434 - $151,151	1,661 Added 4.34%	39,898 $3.47 Million
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $300,169 - $337,889	3,709 Added 10.74%	38,237 $3.34 Million
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $51,801 - $72,574	-733 Reduced 2.08%	34,528 $2.85 Million
Q4 2019 Feb 11, 2020	BUY	$84.35 - $95.37 $32,137 - $36,335	381 Added 1.09%	35,261 $3.34 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $369,618 - $407,297	4,321 Added 14.14%	34,880 $3.03 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $18,699 - $23,014	248 Added 0.82%	30,559 $2.79 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $121,867 - $139,390	1,618 Added 5.64%	30,311 $2.91 Million
Q4 2018 Feb 06, 2019	BUY	$73.66 - $82.02 $1.11 Million - $1.23 Million	15,057 Added 110.42%	28,693 $2.46 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $66,940 - $77,430	1,000 Added 7.91%	13,636 $1.18 Million
Q2 2018 Apr 15, 2019	SELL	$64.91 - $73.36 $876,609 - $990,726	-13,505 Reduced 51.66%	12,636 $954,000
Q2 2018 Aug 15, 2018	BUY	$64.91 - $73.36 $858,889 - $970,699	13,232 Added 102.5%	26,141 $1.98 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $293,385 - $350,737	4,168 Added 47.68%	12,909 $1.04 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $13,598 - $14,596	-188 Reduced 2.11%	8,741 $734,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $661,996 - $689,943	8,929	8,929 $767,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account